Læknaneminn


Læknaneminn - 01.04.1997, Síða 118

Læknaneminn - 01.04.1997, Síða 118
Peter Duesberg and David Rasnick antivirals since I’ve been following them since the very beginning... They’ve watched all of their friends go on the antiretroviral bandwagon and die, so they’ve chose to remain naive to therapy. More and more, however, are now succumbing to pressure that protease inhibitors are it ... We are in the middle of the honey- moon period, and whether or not this is going to be an enduring marriage is unclear to me at this time, so I’m advising my patients if they still have time, to wait.” 180 Unknowingly the vast majority of HlV-positives are long-term survivors! Worldwide, they number 17 mil- lion, including 1 million HlV-positive, healthy Americans and 0.5 million HlV-positive, healthy Europeans 269, 27°. Most of these must have been HIV- positive for at least 10 years now because the numbers of the HlV-positive Americans and Europeans have not changed during the period 1984 to 1988 when the epi- demic of HlV-testing began in the respective countries 26'29 (Fig.l). Since no more than 6% of the 17 million people worldwide with antibodies to HIV have developed AIDS over the last 7 to 10 years, the risk of AIDS to an HlV-carrier is less than 1% peryear 27°. However, even this low figure is not corrected for the normal occurence of the 30 AIDS-defming diseases in HIV- free controls. There is not a single controlled study in the vast AIDS literature proving that HlV-positive peo- ple who are not drug users have a higher morbidity or mortality than HlV-free controls n’225. (See 7., Tables 4 and 5) To save the reputation of the “deadly virus” in the face of long-term survivors, orthodox HIV researchers have already posted warnings that “regrettably ... the proportion of individuals who might demonstrate such a benign course is very small” 271. Others have postu- lated rare HIV attenuating mutations without provid- ing functional evidence 248,25°. Gallo et al. went even further by postulating human mutants, who fall victim of HIV because they lack “major HlV-suppressive fac- tors” 272. According to Gallo’s hypothesis most American homosexuals, hemophiliacs and intravenous drug users are mutants! 2) Drug users developing AIDSprior to HIV infection. Prospective studies have demonstrated that the T-cells of male homosexuals using psychoactive drugs and sex- ual stimulants may decline prior to infection with HIV. For example, the T-cells of 37 homosexual men from San Francisco declined steadily prior to HIV infection for 1.5 years from over 1200 to below 800 per pl 273. Some even had fewer than 500 T-cells 1.5 years before seroconversion 274. Although recreational drug use was not mentioned in these articles, other studies of the same cohort of homosexual men from San Francisco described extensive use of recreational drugs including nitrites 80, 112, 1K l45,275. Likewise, 33 HlV-free male homosexuals from Vancouver, Canada, had "acquired” immunodeficiency prior to HIV infection 276. Again this study did not mention drug use, but in other arti- cles the authors reported that all men of this cohort had used nitrites, cocaine and amphetamines 4a-,K-2T7. The MAC study reported that about 450 (16% of 2795) HlV-free, homosexual American men from Chicago, Baltimore, Pittsburgh and Los Angeles had acquired immunodeficiency, having less than 600 T- cells per pl, prior to HIV infection 103. Many HIV- positive and -negative men of this cohort had essential- ly the same degree of lymphadenopathy: "Although seropositive men had a significantly higher mean num- ber of involved lymphnode groups than seronegative men (5.7 compared to 4.5 nodes, p<0.005), the numerical difference in the means is not striking” 27S. According to previous studies on this cohort, 71% of these men had used -based on self reporting- nitrite inhalants, in addition to other drugs 278; 83% had used one drug, and 60% had used two or more drugs dur- ing sex in the previous six months 279. Indeed, not a single prospective study of male homo- sexual cohorts at risk for AIDS ever measured drug use directly. Instead, each relied only on self reporting, using questionnaires that focused on recent use of a few selective drugs 31-48,229,275 (see 7.). By contrast, all HIV tests were based on experimental methods that maxi- mize positivity such as antibodies against the virus instead of the virus itself, or amplification of fragments of viral nucleic acid instead of standard infectivity tests (see 7.). Another study of the same cohort observed that the risk of developing AIDS correlated with the frequency of receptive anal intercourse prior to and after HIV infection 280, which correlates directly with the use of nitrite vasodilaters 26,10°’104,130,281 (see 3.). Thus, in male homosexuals at risk for AIDS, AIDS often precedes infection by HIV, not vice versa. Since LÆKNANEMINN 116 1. tbl. 1997, 50. árg.
Síða 1
Síða 2
Síða 3
Síða 4
Síða 5
Síða 6
Síða 7
Síða 8
Síða 9
Síða 10
Síða 11
Síða 12
Síða 13
Síða 14
Síða 15
Síða 16
Síða 17
Síða 18
Síða 19
Síða 20
Síða 21
Síða 22
Síða 23
Síða 24
Síða 25
Síða 26
Síða 27
Síða 28
Síða 29
Síða 30
Síða 31
Síða 32
Síða 33
Síða 34
Síða 35
Síða 36
Síða 37
Síða 38
Síða 39
Síða 40
Síða 41
Síða 42
Síða 43
Síða 44
Síða 45
Síða 46
Síða 47
Síða 48
Síða 49
Síða 50
Síða 51
Síða 52
Síða 53
Síða 54
Síða 55
Síða 56
Síða 57
Síða 58
Síða 59
Síða 60
Síða 61
Síða 62
Síða 63
Síða 64
Síða 65
Síða 66
Síða 67
Síða 68
Síða 69
Síða 70
Síða 71
Síða 72
Síða 73
Síða 74
Síða 75
Síða 76
Síða 77
Síða 78
Síða 79
Síða 80
Síða 81
Síða 82
Síða 83
Síða 84
Síða 85
Síða 86
Síða 87
Síða 88
Síða 89
Síða 90
Síða 91
Síða 92
Síða 93
Síða 94
Síða 95
Síða 96
Síða 97
Síða 98
Síða 99
Síða 100
Síða 101
Síða 102
Síða 103
Síða 104
Síða 105
Síða 106
Síða 107
Síða 108
Síða 109
Síða 110
Síða 111
Síða 112
Síða 113
Síða 114
Síða 115
Síða 116
Síða 117
Síða 118
Síða 119
Síða 120
Síða 121
Síða 122
Síða 123
Síða 124
Síða 125
Síða 126
Síða 127
Síða 128
Síða 129
Síða 130
Síða 131
Síða 132
Síða 133
Síða 134
Síða 135
Síða 136
Síða 137
Síða 138
Síða 139
Síða 140

x

Læknaneminn

Beinleiðis leinki

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknaneminn
https://timarit.is/publication/1885

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.